Chemical Tools To Monitor and Manipulate Adaptive Immune Responses.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 27115249)

Published in J Am Chem Soc on May 03, 2016

Authors

Todd M Doran1, Mohosin Sarkar1, Thomas Kodadek1

Author Affiliations

1: Departments of Chemistry and Cancer Biology, The Scripps Research Institute , 130 Scripps Way, Jupiter, Florida 33458, United States.

Articles cited by this

(truncated to the top 100)

Revised diagnostic criteria for neuromyelitis optica. Neurology (2006) 17.57

Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia. N Engl J Med (2013) 16.33

IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med (2005) 10.39

Chronic lymphocytic leukemia. N Engl J Med (2005) 9.99

A new type of synthetic peptide library for identifying ligand-binding activity. Nature (1991) 7.81

The growing impact of click chemistry on drug discovery. Drug Discov Today (2003) 6.79

The NOD mouse: a model of immune dysregulation. Annu Rev Immunol (2005) 6.71

Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature (1990) 6.71

Controlling signal transduction with synthetic ligands. Science (1993) 6.70

The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. Proc Natl Acad Sci U S A (2007) 6.44

Type I diabetes mellitus. A chronic autoimmune disease. N Engl J Med (1986) 6.11

Idelalisib and rituximab in relapsed chronic lymphocytic leukemia. N Engl J Med (2014) 6.06

Generation of functional human pancreatic β cells in vitro. Cell (2014) 5.90

The T lymphocyte in experimental allergic encephalomyelitis. Annu Rev Immunol (1990) 5.36

Generation and use of synthetic peptide combinatorial libraries for basic research and drug discovery. Nature (1991) 5.30

Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature (1993) 5.10

Immune checkpoint blockade: a common denominator approach to cancer therapy. Cancer Cell (2015) 5.10

Multiplexed particle-based flow cytometric assays. J Immunol Methods (2000) 5.09

RNA-peptide fusions for the in vitro selection of peptides and proteins. Proc Natl Acad Sci U S A (1997) 5.06

Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes (1996) 4.20

Peptoids: a modular approach to drug discovery. Proc Natl Acad Sci U S A (1992) 4.08

Early expression of antiinsulin autoantibodies of humans and the NOD mouse: evidence for early determination of subsequent diabetes. Proc Natl Acad Sci U S A (2000) 3.89

Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica. Neurology (2007) 3.83

Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies. Nature (2014) 3.73

Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children. JAMA (2013) 3.65

B-cell targeting in rheumatoid arthritis and other autoimmune diseases. Nat Rev Immunol (2006) 3.20

Identification of candidate IgG biomarkers for Alzheimer's disease via combinatorial library screening. Cell (2011) 3.01

Synthesis of N-substituted glycine peptoid libraries. Methods Enzymol (1996) 2.97

Isolation of protein ligands from large peptoid libraries. J Am Chem Soc (2003) 2.80

The mechanism of action of cyclosporin A and FK506. Clin Immunol Immunopathol (1996) 2.77

VDJ recombination. Immunol Today (1992) 2.74

Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review. Ann Rheum Dis (2006) 2.68

Antigen microarrays identify unique serum autoantibody signatures in clinical and pathologic subtypes of multiple sclerosis. Proc Natl Acad Sci U S A (2008) 2.57

The promise and challenge of high-throughput sequencing of the antibody repertoire. Nat Biotechnol (2014) 2.54

Lipid microarrays identify key mediators of autoimmune brain inflammation. Nat Med (2005) 2.31

The sentinel within: exploiting the immune system for cancer biomarkers. J Proteome Res (2005) 2.22

Controlling protein association and subcellular localization with a synthetic ligand that induces heterodimerization of proteins. Proc Natl Acad Sci U S A (1996) 2.20

Stereotyped B-cell receptors in one-third of chronic lymphocytic leukemia: a molecular classification with implications for targeted therapies. Blood (2012) 2.14

Autoantibodies in diabetes. Diabetes (2005) 1.96

Chimeric antigen receptor therapy for cancer. Annu Rev Med (2013) 1.94

Three-part inventions: intracellular signaling and induced proximity. Trends Biochem Sci (1996) 1.87

Chemically programmed monoclonal antibodies for cancer therapy: adaptor immunotherapy based on a covalent antibody catalyst. Proc Natl Acad Sci U S A (2003) 1.78

A plasmonic chip for biomarker discovery and diagnosis of type 1 diabetes. Nat Med (2014) 1.72

A comprehensive guide to antibody and T-cell responses in type 1 diabetes. Tissue Antigens (2003) 1.71

Seamless bead to microarray screening: rapid identification of the highest affinity protein ligands from large combinatorial libraries. Chem Biol (2010) 1.67

Detection of anti-aquaporin-4 antibodies in neuromyelitis optica: current status of the assays. Int MS J (2008) 1.61

Differential expression of GAD65 and GAD67 in human, rat, and mouse pancreatic islets. Diabetes (1993) 1.61

Bruton tyrosine kinase (BTK) and its role in B-cell malignancy. Int Rev Immunol (2012) 1.61

Chemistry of periodate-mediated cross-linking of 3,4-dihydroxylphenylalanine-containing molecules to proteins. J Am Chem Soc (2006) 1.60

Ipilimumab (Yervoy) and the TGN1412 catastrophe. Immunobiology (2011) 1.53

Identification and characterization of the constituent human serum antibodies elicited by vaccination. Proc Natl Acad Sci U S A (2014) 1.50

A biomimetic polyketide-inspired approach to small-molecule ligand discovery. Nat Chem (2011) 1.49

Detection of GAD65 antibodies in diabetes and other autoimmune diseases using a simple radioligand assay. Diabetes (1994) 1.48

Diagnosis of Alzheimer's disease based on disease-specific autoantibody profiles in human sera. PLoS One (2011) 1.46

International Workshop on Lessons From Animal Models for Human Type 1 Diabetes: identification of insulin but not glutamic acid decarboxylase or IA-2 as specific autoantigens of humoral autoimmunity in nonobese diabetic mice. Diabetes (2001) 1.42

Synthesis and screening of stereochemically diverse combinatorial libraries of peptide tertiary amides. Chem Biol (2013) 1.32

A nonredundant human protein chip for antibody screening and serum profiling. Mol Cell Proteomics (2003) 1.31

Islet cell autoantigens in insulin-dependent diabetes. J Clin Invest (1993) 1.28

Screening bicyclic peptide libraries for protein-protein interaction inhibitors: discovery of a tumor necrosis factor-α antagonist. J Am Chem Soc (2013) 1.24

Periodate-triggered cross-linking of DOPA-containing peptide-protein complexes. J Am Chem Soc (2004) 1.24

Synthetic ligands discovered by in vitro selection. J Am Chem Soc (2007) 1.24

Peptoid architectures: elaboration, actuation, and application. Curr Opin Chem Biol (2008) 1.24

Quantum dots as a visual aid for screening bead-bound combinatorial libraries. Chembiochem (2003) 1.20

GAD65 autoantibodies detected by electrochemiluminescence assay identify high risk for type 1 diabetes. Diabetes (2013) 1.19

Recent advances in the construction of antibody-drug conjugates. Nat Chem (2016) 1.18

Application of immunosignatures to the assessment of Alzheimer's disease. Ann Neurol (2011) 1.17

Chemical control over immune recognition: a class of antibody-recruiting small molecules that target prostate cancer. J Am Chem Soc (2009) 1.17

Antibody-recruiting molecules: an emerging paradigm for engaging immune function in treating human disease. ACS Chem Biol (2012) 1.17

Cleavable hydrophilic linker for one-bead-one-compound sequencing of oligomer libraries by tandem mass spectrometry. J Comb Chem (2006) 1.15

Barcode-enabled sequencing of plasmablast antibody repertoires in rheumatoid arthritis. Arthritis Rheumatol (2014) 1.14

High-throughput sequencing of natively paired antibody chains provides evidence for original antigenic sin shaping the antibody response to influenza vaccination. Clin Immunol (2014) 1.12

Incorporation of heterocycles into the backbone of peptoids to generate diverse peptoid-inspired one bead one compound libraries. ACS Comb Sci (2012) 1.11

Proinsulin/Insulin autoantibodies measured with electrochemiluminescent assay are the earliest indicator of prediabetic islet autoimmunity. Diabetes Care (2013) 1.11

A humanized aldolase antibody for selective chemotherapy and adaptor immunotherapy. J Mol Biol (2003) 1.11

Utility of redundant combinatorial libraries in distinguishing high and low quality screening hits. ACS Comb Sci (2014) 1.10

Experimental autoimmune encephalomyelitis (EAE). Curr Protoc Neurosci (2001) 1.07

Synthesis of libraries of peptidomimetic compounds containing a 2-oxopiperazine unit in the main chain. Org Biomol Chem (2013) 1.05

Protein arrays for autoantibody profiling and fine-specificity mapping. Proteomics (2003) 1.04

Potent and selective photo-inactivation of proteins with peptoid-ruthenium conjugates. Nat Chem Biol (2010) 1.03

Total synthesis of the nematicidal cyclododecapeptide omphalotin A by using racemization-free triphosgene-mediated couplings in the solid phase. Angew Chem Int Ed Engl (2002) 1.01

Maturation of the humoral autoimmune response to epitopes of GAD in preclinical childhood type 1 diabetes. Diabetes (2000) 1.01

Isolation of antagonists of antigen-specific autoimmune T cell proliferation. Chem Biol (2009) 1.00

The flexizyme system: a highly flexible tRNA aminoacylation tool for the translation apparatus. Curr Opin Chem Biol (2007) 0.97

Checkpoint blockade for cancer therapy: revitalizing a suppressed immune system. Trends Mol Med (2015) 0.96

Protein and peptide array analysis of autoimmune disease. Biotechniques (2002) 0.96

Discovery of native autoantigens via antigen surrogate technology: application to type 1 diabetes. ACS Chem Biol (2014) 0.95

Selecting chemicals: the emerging utility of DNA-encoded libraries. Curr Opin Chem Biol (2010) 0.95

Anti-aquaporin-4 auto-antibodies orchestrate the pathogenesis in neuromyelitis optica. Autoimmun Rev (2009) 0.93

A liquid array platform for the multiplexed analysis of synthetic molecule-protein interactions. ACS Chem Biol (2013) 0.93

DNA-Encoded Solid-Phase Synthesis: Encoding Language Design and Complex Oligomer Library Synthesis. ACS Comb Sci (2015) 0.92

A chemically induced vaccine strategy for prostate cancer. ACS Chem Biol (2011) 0.92

Poly-N-methylated alpha-peptides: synthesis and X-ray structure determination of beta-strand forming foldamers. Chem Commun (Camb) (2005) 0.91

Type 1 diabetes in children. BMJ (2011) 0.90

Decoding split and pool combinatorial libraries with electron-transfer dissociation tandem mass spectrometry. J Am Soc Mass Spectrom (2013) 0.89

Human autoantibodies react with glutamic acid decarboxylase antigen in human and rat but not in mouse pancreatic islets. Diabetologia (1993) 0.89

Chemically synthesized molecules with the targeting and effector functions of antibodies. J Am Chem Soc (2014) 0.89

Recognition of antigen-specific B-cell receptors from chronic lymphocytic leukemia patients by synthetic antigen surrogates. Chem Biol (2014) 0.88

Immune Checkpoint Blockade in Cancer Therapy: The 2015 Lasker-DeBakey Clinical Medical Research Award. JAMA (2015) 0.88

Robust Suzuki-Miyaura cross-coupling on DNA-linked substrates. ACS Comb Sci (2014) 0.87

Recent advances of protein microarrays. Curr Opin Chem Biol (2005) 0.86